Safety and Efficacy of dulaglutide therapy for perioperative glycaemic control
Not Applicable
- Conditions
- type2 diabetes
- Registration Number
- JPRN-UMIN000024342
- Lead Sponsor
- Ichinomiyanishi hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Not provided
Exclusion Criteria
Patients admitted to or expected to require ICU admission or cardiac surgery or abdminal surgery; patients with a history of pancreatitis or corticosteroid therapy, clinically relevant hepatic disease,or impaired renal function (serum creatinine >3.0 mg/dL); and patients with a history of diabetic ketoacidosis, pregnancy, or any mental condition rendering the subject unable to give informed consent.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Data of CGM pre-operation,post-operation,day1,day2
- Secondary Outcome Measures
Name Time Method